Literature DB >> 20031094

Exploratory data mining analysis identifying subgroups of patients with depression who are at high risk for suicide.

Mark A Ilgen1, Karen Downing, Kara Zivin, Katherine J Hoggatt, H Myra Kim, Dara Ganoczy, Karen L Austin, John F McCarthy, Jignesh M Patel, Marcia Valenstein.   

Abstract

OBJECTIVE: Although prior research has identified a number of separate risk factors for suicide among patients with depression, little is known about how these factors may interact to modify suicide risk. Using an empirically based decision tree analysis for a large national sample of Veterans Affairs (VA) health system patients treated for depression, we identified subgroups with particularly high or low rates of suicide.
METHOD: We identified 887,859 VA patients treated for depression between April 1, 1999, and September 30, 2004. Randomly splitting the data into 2 samples (primary and replication samples), we developed a decision tree for the primary sample using recursive partitioning. We then tested whether the groups developed within the primary sample were associated with increased suicide risk in the replication sample.
RESULTS: The exploratory data analysis produced a decision tree with subgroups of patients at differing levels of risk for suicide. These were identified by a combination of factors including a co-occurring substance use disorder diagnosis, male sex, African American race, and psychiatric hospitalization in the past year. The groups developed as part of the decision tree accurately discriminated between those with and without suicide in the replication sample. The patients at highest risk for suicide were those with a substance use disorder who were non-African American and had an inpatient psychiatric stay within the past 12 months.
CONCLUSIONS: Study findings suggest that the identification of depressed patients at increased risk for suicide is improved through the examination of higher order interactions between potential risk factors. Copyright 2009 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 20031094      PMCID: PMC3057750          DOI: 10.4088/JCP.08m04795

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  17 in total

Review 1.  A primer and comparative review of major US mortality databases.

Authors:  Diane C Cowper; Joseph D Kubal; Charles Maynard; Denise M Hynes
Journal:  Ann Epidemiol       Date:  2002-10       Impact factor: 3.797

2.  Affective disorders and suicide risk: a reexamination.

Authors:  J M Bostwick; V S Pankratz
Journal:  Am J Psychiatry       Date:  2000-12       Impact factor: 18.112

Review 3.  Application of data mining techniques to healthcare data.

Authors:  Mary K Obenshain
Journal:  Infect Control Hosp Epidemiol       Date:  2004-08       Impact factor: 3.254

4.  Risk factors for suicide in blacks and whites: an analysis of data from the 1993 National Mortality Followback Survey.

Authors:  Kathryn Castle; Paul R Duberstein; Sean Meldrum; Kenneth R Conner; Yeates Conwell
Journal:  Am J Psychiatry       Date:  2004-03       Impact factor: 18.112

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study.

Authors:  Y Conwell; P R Duberstein; C Cox; J H Herrmann; N T Forbes; E D Caine
Journal:  Am J Psychiatry       Date:  1996-08       Impact factor: 18.112

7.  Suicide risk in relation to socioeconomic, demographic, psychiatric, and familial factors: a national register-based study of all suicides in Denmark, 1981-1997.

Authors:  Ping Qin; Esben Agerbo; Preben Bo Mortensen
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

8.  Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia.

Authors:  H M Inskip; E C Harris; B Barraclough
Journal:  Br J Psychiatry       Date:  1998-01       Impact factor: 9.319

9.  Mental disorder in elderly suicides: a case-control study.

Authors:  Margda Waern; Bo S Runeson; Peter Allebeck; Jan Beskow; Eva Rubenowitz; Ingmar Skoog; Katarina Wilhelmsson
Journal:  Am J Psychiatry       Date:  2002-03       Impact factor: 18.112

10.  Mental disorders and comorbidity in suicide.

Authors:  M M Henriksson; H M Aro; M J Marttunen; M E Heikkinen; E T Isometsä; K I Kuoppasalmi; J K Lönnqvist
Journal:  Am J Psychiatry       Date:  1993-06       Impact factor: 18.112

View more
  11 in total

1.  Suicide among veterans in 16 states, 2005 to 2008: comparisons between utilizers and nonutilizers of Veterans Health Administration (VHA) services based on data from the National Death Index, the National Violent Death Reporting System, and VHA administrative records.

Authors:  Ira R Katz; John F McCarthy; Rosalinda V Ignacio; Janet Kemp
Journal:  Am J Public Health       Date:  2012-01-25       Impact factor: 9.308

2.  Finding potentially new multimorbidity patterns of psychiatric and somatic diseases: exploring the use of literature-based discovery in primary care research.

Authors:  Rein Vos; Sil Aarts; Erik van Mulligen; Job Metsemakers; Martin P van Boxtel; Frans Verhey; Marjan van den Akker
Journal:  J Am Med Inform Assoc       Date:  2013-06-17       Impact factor: 4.497

Review 3.  The use of electronic health records for psychiatric phenotyping and genomics.

Authors:  Jordan W Smoller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-05-30       Impact factor: 3.568

4.  Gender Differences in Machine Learning Models of Trauma and Suicidal Ideation in Veterans of the Iraq and Afghanistan Wars.

Authors:  Jaimie L Gradus; Matthew W King; Isaac Galatzer-Levy; Amy E Street
Journal:  J Trauma Stress       Date:  2017-07-25

5.  Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine.

Authors:  Todd Zorick; Catherine A Sugar; Gerhard Hellemann; Steve Shoptaw; Edythe D London
Journal:  Drug Alcohol Depend       Date:  2011-05-17       Impact factor: 4.492

Review 6.  Supervised Machine Learning: A Brief Primer.

Authors:  Tammy Jiang; Jaimie L Gradus; Anthony J Rosellini
Journal:  Behav Ther       Date:  2020-05-16

7.  The effects of co-morbidity in defining major depression subtypes associated with long-term course and severity.

Authors:  K J Wardenaar; H M van Loo; T Cai; M Fava; M J Gruber; J Li; P de Jonge; A A Nierenberg; M V Petukhova; S Rose; N A Sampson; R A Schoevers; M A Wilcox; J Alonso; E J Bromet; B Bunting; S E Florescu; A Fukao; O Gureje; C Hu; Y Q Huang; A N Karam; D Levinson; M E Medina Mora; J Posada-Villa; K M Scott; N I Taib; M C Viana; M Xavier; Z Zarkov; R C Kessler
Journal:  Psychol Med       Date:  2014-07-17       Impact factor: 7.723

8.  Meta-analysis of the strength of exploratory suicide prediction models; from clinicians to computers.

Authors:  Michelle Corke; Katherine Mullin; Helena Angel-Scott; Shelley Xia; Matthew Large
Journal:  BJPsych Open       Date:  2021-01-07

9.  Major depressive disorder subtypes to predict long-term course.

Authors:  Hanna M van Loo; Tianxi Cai; Michael J Gruber; Junlong Li; Peter de Jonge; Maria Petukhova; Sherri Rose; Nancy A Sampson; Robert A Schoevers; Klaas J Wardenaar; Marsha A Wilcox; Ali Obaid Al-Hamzawi; Laura Helena Andrade; Evelyn J Bromet; Brendan Bunting; John Fayyad; Silvia E Florescu; Oye Gureje; Chiyi Hu; Yueqin Huang; Daphna Levinson; Maria Elena Medina-Mora; Yoshibumi Nakane; Jose Posada-Villa; Kate M Scott; Miguel Xavier; Zahari Zarkov; Ronald C Kessler
Journal:  Depress Anxiety       Date:  2014-01-14       Impact factor: 6.505

10.  Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder.

Authors:  Lan-Ying Liu; Hong-Jian Zhang; Li-Yuan Luo; Jin-Bao Pu; Wei-Qing Liang; Chun-Qin Zhu; Ya-Ping Li; Pei-Rong Wang; Yuan-Yuan Zhang; Chun-Yu Yang; Zhang-Jin Zhang
Journal:  Chin Med       Date:  2018-10-25       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.